日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The risk of cardiovascular events following community-acquired sepsis: a nationwide cohort study in Sweden

社区获得性脓毒症后发生心血管事件的风险：一项瑞典全国性队列研究

期刊:Epidemiology and Infection
影响因子:2.2
doi:10.1017/S0950268826101174
Wetterberg, Hanna; Nilsson, Anton; Linder, Adam; Lengquist, Maria; Frigyesi, Attila; Sundén-Cullberg, Jonas; Inghammar, Malin
炎症/感染
败血症
发表日期：2026
文献求助 收藏

Calprotectin as a sepsis diagnostic marker in critical care: a retrospective observational study

钙卫蛋白作为重症监护中脓毒症诊断标志物：一项回顾性观察研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-95420-0
Lengquist, Maria; Sundén-Cullberg, Vera; Hyllner, Sofie; Koozi, Hazem; Larsson, Anders; Mellhammar, Lisa; Friberg, Hans; Schiopu, Alexandru; Frigyesi, Attila
败血症
炎症/感染
发表日期：2025
文献求助 收藏

A Phase I open-label study to assess the pharmacokinetics, safety, and tolerability of capivasertib alone or in combination with paclitaxel in Chinese patients with advanced solid tumors

一项 I 期开放标签研究，旨在评估卡帕替尼单药或联合紫杉醇治疗中国晚期实体瘤患者的药代动力学、安全性和耐受性。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14982-4
Zhang, Jian; Liu, Xiaojun; Du, Yiqun; Mu, Yuxin; Meng, Yanchun; Sun, Yan; Zhang, Ling; Chen, Chris; Cullberg, Marie; Fan, Ethan; Hu, Xichun
发表日期：2025
文献求助 收藏

Population Pharmacokinetics and Exposure-Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer

卡帕替尼联合氟维司群治疗乳腺癌患者的群体药代动力学和暴露-反应分析

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70286
Fernandez Teruel, Carlos; Cullberg, Marie; González-García, Ignacio; Schiavon, Gaia; Zhang, Ling; Zhou, Diansong
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

An exposure-safety analysis to support the dosage of the novel AKT inhibitor capivasertib

一项暴露-安全性分析，旨在支持新型 AKT 抑制剂 capivasertib 的剂量。

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-025-04775-8
Teruel, Carlos Fernandez; Cullberg, Marie; González-García, Ignacio; Schiavon, Gaia; Zhou, Diansong
AKT
发表日期：2025
文献求助 收藏

Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours

卡帕替尼在晚期或转移性实体瘤患者中的群体药代动力学

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-024-01407-x
Fernandez-Teruel, Carlos; Cullberg, Marie; Eberlein, Cath; Barry, Simon T; Zhou, Diansong
发表日期：2024
文献求助 收藏

Long-term Mortality and Hospital Readmissions Among Survivors of Sepsis in Sweden: A Population-Based Cohort Study

瑞典脓毒症幸存者长期死亡率和再入院率：一项基于人群的队列研究

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofae331
Inghammar, Malin; Linder, Adam; Lengquist, Maria; Frigyesi, Attila; Wetterberg, Hanna; Sundén-Cullberg, Jonas; Nilsson, Anton
败血症
炎症/感染
发表日期：2024
文献求助 收藏

Pharmacokinetic study of capivasertib and the CYP3A4 substrate midazolam in patients with advanced solid tumors

卡帕替尼和CYP3A4底物咪达唑仑在晚期实体瘤患者中的药代动力学研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-024-04667-3
Miller, Claire; Sommavilla, Roberto; O'Bryant, Cindy L; Barve, Minal; Dowlati, Afshin; Luke, Jason J; Khatun, Mahmuda; Morris, Thomas; Cullberg, Marie
CYP3A4
发表日期：2024
文献求助 收藏

Plasma calprotectin as an indicator of need of transfer to intensive care in patients with suspected sepsis at the emergency department

血浆钙卫蛋白作为急诊科疑似脓毒症患者转入重症监护室的指标

期刊:BMC Emergency Medicine
影响因子:2.6
doi:10.1186/s12873-023-00785-y
Parke, Åsa; Unge, Christian; Yu, David; Sundén-Cullberg, Jonas; Strålin, Kristoffer
炎症/感染
败血症
发表日期：2023
文献求助 收藏

Sex-based differences in ED management of critically ill patients with sepsis: a nationwide cohort study

脓毒症危重患者急诊治疗中基于性别的差异：一项全国性队列研究

期刊:Intensive Care Medicine
影响因子:21.2
doi:10.1007/s00134-019-05910-9
Sunden-Cullberg, Jonas; Nilsson, Anton; Inghammar, Malin
败血症
炎症/感染
发表日期：2020
文献求助 收藏